WO2003037296A3 - Methods and dosage forms for improving the bioavailability of therapeutic agents - Google Patents
Methods and dosage forms for improving the bioavailability of therapeutic agents Download PDFInfo
- Publication number
- WO2003037296A3 WO2003037296A3 PCT/EP2002/012062 EP0212062W WO03037296A3 WO 2003037296 A3 WO2003037296 A3 WO 2003037296A3 EP 0212062 W EP0212062 W EP 0212062W WO 03037296 A3 WO03037296 A3 WO 03037296A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dosage form
- therapeutic agent
- release
- dosage forms
- bioavailability
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003539640A JP2005509643A (en) | 2001-10-29 | 2002-10-29 | Methods and dosage forms for improving the bioavailability of therapeutic agents |
AU2002351798A AU2002351798A1 (en) | 2001-10-29 | 2002-10-29 | Methods and dosage forms for improving the bioavailability of therapeutic agents |
EP02787522A EP1439820A2 (en) | 2001-10-29 | 2002-10-29 | Methods and dosage forms for improving the bioavailability of therapeutic agents |
MXPA04004035A MXPA04004035A (en) | 2001-10-29 | 2002-10-29 | Methods and dosage forms for improving the bioavailability of therapeutic agents. |
CA002466032A CA2466032A1 (en) | 2001-10-29 | 2002-10-29 | Methods and dosage forms for improving the bioavailability of therapeutic agents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01125761.5 | 2001-10-29 | ||
EP01125761 | 2001-10-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003037296A2 WO2003037296A2 (en) | 2003-05-08 |
WO2003037296A3 true WO2003037296A3 (en) | 2003-12-24 |
Family
ID=8179102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/012062 WO2003037296A2 (en) | 2001-10-29 | 2002-10-29 | Methods and dosage forms for improving the bioavailability of therapeutic agents |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1439820A2 (en) |
JP (1) | JP2005509643A (en) |
AU (1) | AU2002351798A1 (en) |
CA (1) | CA2466032A1 (en) |
MX (1) | MXPA04004035A (en) |
WO (1) | WO2003037296A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8962019B2 (en) | 2005-09-09 | 2015-02-24 | Angelini Pharma, Inc. | Sustained drug release composition |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
JP5355002B2 (en) * | 2008-09-10 | 2013-11-27 | オリンパスメディカルシステムズ株式会社 | Floating amount acceptance / rejection determination system, floating amount acceptance / rejection determination display system, floating amount acceptance / rejection determination method, and floating amount acceptance / rejection determination display method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998055107A1 (en) * | 1997-06-06 | 1998-12-10 | Depomed, Inc. | Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs |
WO2000015198A1 (en) * | 1998-09-14 | 2000-03-23 | Ranbaxy Laboratories Limited | Orally administered controlled drug delivery system providing temporal and spatial control |
WO2001010405A1 (en) * | 1999-08-04 | 2001-02-15 | Ranbaxy Laboratories Limited | Hydrodynamically balanced oral drug delivery system |
WO2001058424A1 (en) * | 2000-02-09 | 2001-08-16 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Floating drug delivery composition |
-
2002
- 2002-10-29 MX MXPA04004035A patent/MXPA04004035A/en unknown
- 2002-10-29 CA CA002466032A patent/CA2466032A1/en not_active Abandoned
- 2002-10-29 EP EP02787522A patent/EP1439820A2/en not_active Withdrawn
- 2002-10-29 AU AU2002351798A patent/AU2002351798A1/en not_active Abandoned
- 2002-10-29 WO PCT/EP2002/012062 patent/WO2003037296A2/en not_active Application Discontinuation
- 2002-10-29 JP JP2003539640A patent/JP2005509643A/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998055107A1 (en) * | 1997-06-06 | 1998-12-10 | Depomed, Inc. | Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs |
WO2000015198A1 (en) * | 1998-09-14 | 2000-03-23 | Ranbaxy Laboratories Limited | Orally administered controlled drug delivery system providing temporal and spatial control |
WO2001010405A1 (en) * | 1999-08-04 | 2001-02-15 | Ranbaxy Laboratories Limited | Hydrodynamically balanced oral drug delivery system |
WO2001058424A1 (en) * | 2000-02-09 | 2001-08-16 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Floating drug delivery composition |
Non-Patent Citations (1)
Title |
---|
NUR AO AND ZHANG JS: "Captopril floating and/or bioadhesive tablets: design and release kinetics", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, vol. 26, no. 9, September 2000 (2000-09-01), ISSN: 0363-9045, pages 965 - 969, XP008002146 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8962019B2 (en) | 2005-09-09 | 2015-02-24 | Angelini Pharma, Inc. | Sustained drug release composition |
Also Published As
Publication number | Publication date |
---|---|
EP1439820A2 (en) | 2004-07-28 |
CA2466032A1 (en) | 2003-05-08 |
WO2003037296A2 (en) | 2003-05-08 |
JP2005509643A (en) | 2005-04-14 |
AU2002351798A1 (en) | 2003-05-12 |
MXPA04004035A (en) | 2004-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001056544A3 (en) | Shell-and-core dosage form approaching zero-order drug release | |
EP1879566B1 (en) | Compositions and methods for inhibiting gastric acid secretion | |
ES2006649A6 (en) | Composition for the oral administration of pharmaceuticals | |
WO2005065654A3 (en) | Rosiglitazone formulations | |
JP2003520223A5 (en) | ||
AP2002002410A0 (en) | Hydrodynamically Balancing Oral Drug Delivery System | |
JP2006527195A (en) | Composition comprising triptan and NSAID | |
HRP20120754T1 (en) | Dosage form containing pantoprazole as active ingredient | |
EA200700158A1 (en) | MEDICAL FORMS WITH A TABLET NUCLEUS, COVERED WITH THE ENTEROROLEUBLISHING SHELL | |
WO2007048223A3 (en) | A gastric retention drug delivery system | |
JP2005510485A5 (en) | ||
WO2004002445A3 (en) | Novel floating dosage form | |
KR20030045035A (en) | Oral fast-melt formulation of a cyclooxygenase-2 inhibitor | |
IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
CA2304948A1 (en) | Pharmaceutical composition for the treatment of inflammatory bowel disease | |
NZ514129A (en) | Tolperison-containing, pharmaceutical preparation for oral administration | |
MY151230A (en) | Novel method | |
AU2009247712B2 (en) | Compositions and methods for inhibiting gastric acid secretion | |
WO2003037296A3 (en) | Methods and dosage forms for improving the bioavailability of therapeutic agents | |
JP2003504338A5 (en) | ||
HUP0203148A2 (en) | Orally distintegrating composition comprising mirtazapine | |
WO2006023295A3 (en) | Pharmaceutical compositions comprising effervescent agents and fenofibrate | |
WO2002069968A8 (en) | New use | |
JPH0747534B2 (en) | Tablets | |
WO2003037301A3 (en) | Oral dosage forms for improving the bioavailability of therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2466032 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/004035 Country of ref document: MX Ref document number: 2003539640 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002787522 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002787522 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002787522 Country of ref document: EP |